Sheldon M. Epstein

1.1k total citations
28 papers, 873 citations indexed

About

Sheldon M. Epstein is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Sheldon M. Epstein has authored 28 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cell Biology and 6 papers in Cancer Research. Recurrent topics in Sheldon M. Epstein's work include Carcinogens and Genotoxicity Assessment (5 papers), Antifungal resistance and susceptibility (3 papers) and Muscle metabolism and nutrition (3 papers). Sheldon M. Epstein is often cited by papers focused on Carcinogens and Genotoxicity Assessment (5 papers), Antifungal resistance and susceptibility (3 papers) and Muscle metabolism and nutrition (3 papers). Sheldon M. Epstein collaborates with scholars based in United States and France. Sheldon M. Epstein's co-authors include Leonard P. Merkow, Emmanuel Farber, James B. Field, Herschel Sidransky, Nobuyuki Ito, Matias Pardo, Ethel Verney, Reuben Chayoth, A. T. Milhorat and I.M. Weinstock and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Sheldon M. Epstein

28 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheldon M. Epstein United States 16 336 167 136 130 114 28 873
Barbara A. Martin United States 18 500 1.5× 75 0.4× 125 0.9× 107 0.8× 57 0.5× 59 1.4k
Jun Yatsunami Japan 19 519 1.5× 161 1.0× 276 2.0× 41 0.3× 82 0.7× 40 1.2k
K. Janakidevi United States 13 413 1.2× 112 0.7× 94 0.7× 22 0.2× 57 0.5× 39 936
R Engler France 14 228 0.7× 72 0.4× 78 0.6× 20 0.2× 58 0.5× 52 698
R. V. Krishnamoorthy India 19 265 0.8× 49 0.3× 111 0.8× 30 0.2× 40 0.4× 98 1.3k
Michael M. Lipsky United States 20 423 1.3× 176 1.1× 140 1.0× 23 0.2× 152 1.3× 39 1.3k
C. M. Goodall New Zealand 16 183 0.5× 138 0.8× 61 0.4× 24 0.2× 38 0.3× 42 663
Franco Dallocchio Italy 19 415 1.2× 90 0.5× 70 0.5× 25 0.2× 129 1.1× 67 1.0k
G Schubert Germany 17 933 2.8× 423 2.5× 181 1.3× 21 0.2× 109 1.0× 38 1.8k
Ward R. Richter United States 16 196 0.6× 82 0.5× 79 0.6× 25 0.2× 73 0.6× 42 755

Countries citing papers authored by Sheldon M. Epstein

Since Specialization
Citations

This map shows the geographic impact of Sheldon M. Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon M. Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon M. Epstein more than expected).

Fields of papers citing papers by Sheldon M. Epstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheldon M. Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon M. Epstein. The network helps show where Sheldon M. Epstein may publish in the future.

Co-authorship network of co-authors of Sheldon M. Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of Sheldon M. Epstein. A scholar is included among the top collaborators of Sheldon M. Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheldon M. Epstein. Sheldon M. Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bernoux, Delphine, et al.. (2023). Impact of continuous glucose monitoring on everyday life of young children with type 1 diabetes and their parents: An evaluation of 114 families. Primary care diabetes. 18(1). 91–96. 5 indexed citations
2.
Epstein, Sheldon M., et al.. (1982). Cyclic nucleotide modulation of in vitro morphological transformation of Syrian hamster cells.. PubMed. 42(4). 1274–8. 4 indexed citations
3.
Epstein, Sheldon M., et al.. (1980). Relationship between morphological transformation and [3H]thymidine incorporation stimulated by a chemical carcinogen in postconfluent cultures of hamster embryo cells.. PubMed. 40(7). 2411–6. 3 indexed citations
4.
Sidransky, Herschel, Sheldon M. Epstein, Ethel Verney, & Robert S. Verbin. (1976). The Effect of Cycloheximide on Hepatic RNA Synthesis and Nucleolar Size in Rats Force-Fed a Threonine-Devoid Diet. Journal of Nutrition. 106(7). 930–939. 7 indexed citations
5.
Merkow, Leonard P., Sheldon M. Epstein, Malcolm Slifkin, & Matias Pardo. (1973). The ultrastructure of renal neoplasms induced by aflatoxin B1.. PubMed. 33(7). 1608–14. 14 indexed citations
6.
Chayoth, Reuben, Sheldon M. Epstein, & James B. Field. (1973). Glucagon and prostaglandin E1 stimulation of cyclic adenosine 3', 5'-monophosphate levels and adenylate cyclase activity in benign hyperplastic nodules and malignant hepatomas of ethionine-treated rats.. PubMed. 33(8). 1970–4. 36 indexed citations
7.
Sidransky, Herschel, et al.. (1972). Experimental visceral aspergillosis.. PubMed. 69(1). 55–70. 26 indexed citations
8.
Witschi, Hanspeter, Sheldon M. Epstein, & Emmanuel Farber. (1971). Influence of liver regeneration on the loss of fluorenylacetamide derivative bound to liver DNA.. PubMed. 31(3). 270–3. 12 indexed citations
9.
Merkow, Leonard P., Sheldon M. Epstein, Herschel Sidransky, Ethel Verney, & Matias Pardo. (1971). The pathogenesis of experimental pulmonary aspergillosis. An ultrastructural study of alveolar macrophages after phagocytosis of a flavus spores in vivo.. PubMed. 62(1). 57–74. 62 indexed citations
10.
Slifkin, Malcolm, Leonard P. Merkow, Matias Pardo, et al.. (1970). Growth in vitro of Cells from Hyperplastic Nodules of Liver Induced by 2-Fluorenylacetamide or Aflatoxin B 1. Science. 167(3916). 285–287. 19 indexed citations
11.
Epstein, Sheldon M., et al.. (1969). Altered and distorted DNA from a premalignant liver lesion induced by 2-fluorenylacetamide. Chemico-Biological Interactions. 1(1). 113–124. 17 indexed citations
12.
Epstein, Sheldon M., et al.. (1969). Renal epithelial neoplasms induced in male Wistar rats by oral aflatoxin B1.. PubMed. 29(5). 1045–50. 38 indexed citations
13.
14.
Epstein, Sheldon M., et al.. (1968). Chemical Carcinogenesis: Persistence of Bound Forms of 2-Fluorenylacetamide. Science. 162(3856). 907–908. 34 indexed citations
15.
Epstein, Sheldon M., Thomas D. Miale, John Moossy, Ethel Verney, & Herschel Sidransky. (1968). EXPERIMENTAL INTRACRANIAL ASPERGILLOSIS. Journal of Neuropathology & Experimental Neurology. 27(3). 473–482. 10 indexed citations
16.
Merkow, Leonard P., Matias Pardo, Sheldon M. Epstein, Ethel Verney, & Herschel Sidransky. (1968). Lysosomal Stability during Phagocytosis of Aspergillus flavus Spores by Alveolar Macrophages of Cortisone-Treated Mice. Science. 160(3823). 79–81. 45 indexed citations
17.
Epstein, Sheldon M., Nobuyuki Ito, Leonard P. Merkow, & Emmanuel Farber. (1967). Cellular analysis of liver carcinogenesis: the induction of large hyperplastic nodules in the liver with 2-fluorenylacetamide or ethionine and some aspects of their morphology and glycogen metabolism.. PubMed. 27(9). 1702–11. 169 indexed citations
18.
Epstein, Sheldon M., E. Verney, Thomas D. Miale, & Herschel Sidransky. (1967). Studies on the pathogenesis of experimental pulmonary aspergillosis.. PubMed. 51(5). 769–88. 48 indexed citations
19.
Epstein, Sheldon M., et al.. (1965). Pyridine nucleotides in the thyroid. Biochimica et Biophysica Acta (BBA) - General Subjects. 100(1). 13–27. 6 indexed citations
20.
Weinstock, I.M., Sheldon M. Epstein, & A. T. Milhorat. (1958). Enzyme Studies in Muscular Dystrophy. III. In Hereditary Muscular Dystrophy in Mice.. Experimental Biology and Medicine. 99(1). 272–276. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara A. Martin Breakdown of academic impact, for papers by Jun Yatsunami Breakdown of academic impact, for papers by K. Janakidevi Breakdown of academic impact, for papers by R Engler Breakdown of academic impact, for papers by R. V. Krishnamoorthy Breakdown of academic impact, for papers by Michael M. Lipsky Breakdown of academic impact, for papers by C. M. Goodall Breakdown of academic impact, for papers by Franco Dallocchio Breakdown of academic impact, for papers by G Schubert Breakdown of academic impact, for papers by Ward R. Richter
Rankless by CCL
2026